Related Experiment Video

Updated: May 25, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

[The progression from hypertension to congestive heart failure]

Francesca Palano1, Francesco Paneni, Sebastiano Sciarretta

  • 1Cattedra e Struttura Complessa di Cardiologia, Dipartmento di Medicine Clinica e Molecolare, Sapienza Università di Romà.

Recenti Progressi in Medicina
|January 20, 2012
PubMed

Insights

Arterial hypertension increases cardiovascular and renal disease risk. Lowering blood pressure with diuretics and renin-angiotensin system blockers effectively prevents heart failure in hypertensive patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Pharmacology

Context:

  • Arterial hypertension is a primary modifiable risk factor for cardiovascular and renal diseases.
  • Hypertension significantly elevates the risk of developing congestive heart failure, independent of left ventricular changes.
  • Blood pressure management is crucial for reducing cardiovascular events and heart failure incidence.

Purpose:

  • To review the pathophysiology linking arterial hypertension to congestive heart failure.
  • To discuss therapeutic strategies for preventing or mitigating this progression.
  • To highlight the comparative efficacy of different antihypertensive drug classes in heart failure prevention.

Summary:

  • Lowering blood pressure through pharmacotherapy substantially reduces major cardiovascular events like myocardial infarction, stroke, and cardiovascular death.
  • Diuretics and renin-angiotensin system blockers have shown superior efficacy over calcium-antagonists and beta-blockers in preventing new-onset heart failure.
  • Understanding the pathophysiological progression from hypertension to heart failure informs targeted therapeutic interventions.

Impact:

  • Provides insights into managing hypertension to prevent severe cardiovascular complications.
  • Informs clinical practice regarding optimal antihypertensive drug selection for heart failure prevention.
  • Contributes to reducing the global burden of cardiovascular and renal diseases.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...